Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1195707

Changes of recommended anticoagulation therapy in patients with atrial fibrillation and high thrombotic risk: long-term follow-up data from two hospital centers


Hadžibegović, Irzal; Jurin, Ivana; Letilović, Tomislav; Radonić, Vedran; Jurin, Hrvoje; Mikšić, Štefica; Lucijanić, Marko
Changes of recommended anticoagulation therapy in patients with atrial fibrillation and high thrombotic risk: long-term follow-up data from two hospital centers // Expert review of cardiovascular therapy, 19 (2021), 9; 857-863 doi:10.1080/14779072.2021.1962293 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1195707 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Changes of recommended anticoagulation therapy in patients with atrial fibrillation and high thrombotic risk: long-term follow-up data from two hospital centers

Autori
Hadžibegović, Irzal ; Jurin, Ivana ; Letilović, Tomislav ; Radonić, Vedran ; Jurin, Hrvoje ; Mikšić, Štefica ; Lucijanić, Marko

Izvornik
Expert review of cardiovascular therapy (1477-9072) 19 (2021), 9; 857-863

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
atrial fibrillation ; anticoagulation ; optimal dosing ; therapy switch ; thromboembolic protection.

Sažetak
Aim : To investigate changes of anticoagulation therapy in patients with atrial fibrillation (AF) and high thrombotic risk.Methods : We retrospectively analyzed 1061 patients with non- valvular AF and indication for anticoagulation therapy referred in a period from 2013 to 2018 and followed-up for a median time of 38 months.Results : Therapy change occurred in 206 (19.5%) patients (195 switches and 11 permanent discontinuations). Only 37% of patients on warfarin had optimal dosing and their duration of therapy was significantly shorter compared to direct oral anticoagulants (DOACs ; (adjusted HR 1.21, 95% CI 1.09-1.37). Therapy change occurred in only 33% of patients with poorly controlled warfarin, and in only 24% of patients that experienced a thrombotic event while taking warfarin. Optimal dosing was an independent factor for any therapy change during follow-up, irrespective of type of anticoagulant drug at baseline. DOAC swapping occurred in 39% of all DOAC to DOAC switches, with one bleeding event and no thrombotic events documented after a DOAC swap.Conclusion : High risk patients with AF rarely discontinue anticoagulation therapy. The need for therapy change should be emphasized in patients with non-optimal dosing, and in patients that experience thrombotic events while taking warfarin.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Hadžibegović, Irzal; Jurin, Ivana; Letilović, Tomislav; Radonić, Vedran; Jurin, Hrvoje; Mikšić, Štefica; Lucijanić, Marko
Changes of recommended anticoagulation therapy in patients with atrial fibrillation and high thrombotic risk: long-term follow-up data from two hospital centers // Expert review of cardiovascular therapy, 19 (2021), 9; 857-863 doi:10.1080/14779072.2021.1962293 (međunarodna recenzija, članak, znanstveni)
Hadžibegović, I., Jurin, I., Letilović, T., Radonić, V., Jurin, H., Mikšić, Š. & Lucijanić, M. (2021) Changes of recommended anticoagulation therapy in patients with atrial fibrillation and high thrombotic risk: long-term follow-up data from two hospital centers. Expert review of cardiovascular therapy, 19 (9), 857-863 doi:10.1080/14779072.2021.1962293.
@article{article, author = {Had\v{z}ibegovi\'{c}, Irzal and Jurin, Ivana and Letilovi\'{c}, Tomislav and Radoni\'{c}, Vedran and Jurin, Hrvoje and Mik\v{s}i\'{c}, \v{S}tefica and Lucijani\'{c}, Marko}, year = {2021}, pages = {857-863}, DOI = {10.1080/14779072.2021.1962293}, keywords = {atrial fibrillation, anticoagulation, optimal dosing, therapy switch, thromboembolic protection.}, journal = {Expert review of cardiovascular therapy}, doi = {10.1080/14779072.2021.1962293}, volume = {19}, number = {9}, issn = {1477-9072}, title = {Changes of recommended anticoagulation therapy in patients with atrial fibrillation and high thrombotic risk: long-term follow-up data from two hospital centers}, keyword = {atrial fibrillation, anticoagulation, optimal dosing, therapy switch, thromboembolic protection.} }
@article{article, author = {Had\v{z}ibegovi\'{c}, Irzal and Jurin, Ivana and Letilovi\'{c}, Tomislav and Radoni\'{c}, Vedran and Jurin, Hrvoje and Mik\v{s}i\'{c}, \v{S}tefica and Lucijani\'{c}, Marko}, year = {2021}, pages = {857-863}, DOI = {10.1080/14779072.2021.1962293}, keywords = {atrial fibrillation, anticoagulation, optimal dosing, therapy switch, thromboembolic protection.}, journal = {Expert review of cardiovascular therapy}, doi = {10.1080/14779072.2021.1962293}, volume = {19}, number = {9}, issn = {1477-9072}, title = {Changes of recommended anticoagulation therapy in patients with atrial fibrillation and high thrombotic risk: long-term follow-up data from two hospital centers}, keyword = {atrial fibrillation, anticoagulation, optimal dosing, therapy switch, thromboembolic protection.} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Emerging Sources Citation Index (ESCI)
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font